Last week the USPTO unveiled its new “Data Visualization Center” which provides patent application pendency, backlog and examination data in a graphic “dashboard” format. While not as fancy, the Board of Appeals and Interferences also has published graphic data on its workload, with monthly statistics from May 2010 to August 2010. The Board’s data show that its backlog continues to grow at a tremendous rate, while its overall reversal rate for the current fiscal year (which ends at the end of September) is about 29%.
Tag Archives: Reversal Rate
Subscribe to This Blog
Topics
- 101
- 102
- 103
- Bilski
- Biosimilars
- Claim Construction
- District Court Decisions
- Doctrine of Equivalents
- Duty of Disclosure
- Enablement
- Federal Circuit Decisions
- Inequitable Conduct
- Infringement
- International Patent Practice
- Life Sciences Agreements
- Myriad
- Obviousness Type Double Patenting
- Patent Office Practice
- Patent Reform
- Patent Term Adjustment
- Patent Term Extension
- Patent Trials
- Personalized Medicine
- Prometheus
- Reasonable Royalty
- Reexam
- Supreme Court Decisions
- Uncategorized
- USPTO Board Decisions
- USPTO Proposed Rule Changes
- Written Description
Recent Updates
Twitter Updates
@PharmaPatents PharmaPatents' Recent Twitter Posts
- RT @LXBN: Supreme Court Finds For Monsanto In Seed Harvesting Case http://t.co/otl9Pbs0Q2 - @PharmaPatents
(about 1 day ago) - RT @priorsmart: Just read: Supreme Court Finds For Monsanto In Seed Harvesting Case - http://t.co/70U6m8vVvw [at @pharmapatents] #patent
(about 1 day ago) - New article: Supreme Court Finds For Monsanto In Seed Harvesting Case http://t.co/EAntMxrPzV ##patent
(about 2 days ago) - RT @BHoopes_Patents: Still can't believe the #CAFC #CLSBank opinion. A wonderful summary of the madness from @PharmaPatents: http://t.co/40…
(about 3 days ago) - @BHoopes_Patents Thanks!
(about 3 days ago)
